- Home
- IPW vs DRRX Comparison
IPW vs DRRX Comparison
Compare IPW & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPW
- DRRX
- Stock Information
- Founded
- IPW 2018
- DRRX 1998
- Country
- IPW United States
- DRRX United States
- Employees
- IPW N/A
- DRRX N/A
- Industry
- IPW Catalog/Specialty Distribution
- DRRX Biotechnology: Pharmaceutical Preparations
- Sector
- IPW Consumer Discretionary
- DRRX Health Care
- Exchange
- IPW Nasdaq
- DRRX Nasdaq
- Market Cap
- IPW 28.0M
- DRRX 26.4M
- IPO Year
- IPW 2021
- DRRX 2000
- Fundamental
- Price
- IPW $0.84
- DRRX $0.85
- Analyst Decision
- IPW Strong Buy
- DRRX Buy
- Analyst Count
- IPW 1
- DRRX 2
- Target Price
- IPW $2.75
- DRRX $5.00
- AVG Volume (30 Days)
- IPW 113.5K
- DRRX 124.4K
- Earning Date
- IPW 02-12-2025
- DRRX 11-13-2024
- Dividend Yield
- IPW N/A
- DRRX N/A
- EPS Growth
- IPW N/A
- DRRX N/A
- EPS
- IPW N/A
- DRRX N/A
- Revenue
- IPW $78,571,632.00
- DRRX $8,594,000.00
- Revenue This Year
- IPW $8.31
- DRRX $54.32
- Revenue Next Year
- IPW $77.15
- DRRX N/A
- P/E Ratio
- IPW N/A
- DRRX N/A
- Revenue Growth
- IPW N/A
- DRRX N/A
- 52 Week Low
- IPW $0.40
- DRRX $0.68
- 52 Week High
- IPW $3.65
- DRRX $1.88
- Technical
- Relative Strength Index (RSI)
- IPW 45.78
- DRRX 47.88
- Support Level
- IPW $0.79
- DRRX $0.79
- Resistance Level
- IPW $1.02
- DRRX $0.86
- Average True Range (ATR)
- IPW 0.09
- DRRX 0.08
- MACD
- IPW 0.00
- DRRX 0.01
- Stochastic Oscillator
- IPW 40.13
- DRRX 51.69
About IPW iPower Inc.
iPower Inc is online hydroponic equipment and accessory retailer and supplier in North America. The company sells products through own website as well as online channel partners that include Amazon, Walmart, and eBay.
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .